Asperlin Inhibits LPS-Evoked Foam Cell Formation and Prevents Atherosclerosis in ApoE−/− Mice
Open Access
- 14 November 2017
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 15 (11) , 358
Abstract
Asperlin is a marine-derived natural product with antifungal and anti-inflammatory activities in vitro. In the present study, we isolated asperlin from a marine Aspergillus versicolor LZD4403 fungus and investigated its anti-atherosclerotic effects in vitro and in vivo. Asperlin significantly inhibited lipopolysaccharides (LPS)- but not oxidated low-density lipoprotein (oxLDL)-evoked foam cell formation and promoted cholesterol efflux in RAW264.7 macrophages. Supplementation with asperlin also suppressed LPS-elicited production of pro-inflammatory factors in RAW264.7 macrophages, decreased the expression levels of iNOS, IL-1β and TNFα, and increased the expression of IL-10 and IL-4, indicating a remarkable shift in M1/M2 macrophages polarization. In vivo experiments in high-fat diet (HFD)-fed ApoE−/− mice showed that oral administration of asperlin for 12 weeks remarkably suppressed atherosclerotic plaque formation in the aorta, as revealed by the reduced aortic dilatation and decreased atherosclerotic lesion area. Asperlin also decreased serum levels of pro-inflammatory factors but showed little impact on blood lipids in ApoE−/− atherosclerotic mice. These results suggested that asperlin is adequate to prevent atherosclerosis in vivo. It may exert atheroprotective function through suppressing inflammation rather than ameliorating dyslipidemia.Keywords
Funding Information
- National Natural Science Foundation of China (81402983;81573436;81673663)
- CAMS Innovation Fund for Medical Sciences (CIFMS) (2016-I2M-3-015)
- PUMC Youth Fund and the Fundamental Research Funds for the Central Universities (33320140185;3332016142)
- National Basic Research Program 973 (2015CB755900)
This publication has 28 references indexed in Scilit:
- Infections, atherosclerosis, and coronary heart diseaseEuropean Heart Journal, 2017
- Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophagesScience, 2017
- Secreted Ectodomain of SIGLEC-9 and MCP-1 Synergistically Improve Acute Liver Failure in Rats by Altering Macrophage PolarityScientific Reports, 2017
- Macrophagic CD146 promotes foam cell formation and retention during atherosclerosisCell Research, 2017
- Modulation of Macrophage Functional Polarity towards Anti-Inflammatory Phenotype with Plasmid DNA Delivery in CD44 Targeting Hyaluronic Acid NanoparticlesScientific Reports, 2015
- Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosisInflammation Research, 2015
- Anti-inflammatory therapies for atherosclerosisNature Reviews Cardiology, 2015
- Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γJournal of Clinical Investigation, 2004
- The macrophage foam cell as a target for therapeutic interventionNature Medicine, 2002
- A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and AtherogenesisMolecular Cell, 2001